EUVIMEDEUVIMED entdecken
Crossref

Preclinical biocompatibility and biosafety evaluation of a new foldable brown diaphragm intraocular lens: An in vitro and in vivo study

Keke Zhang, Shaohua Zhang, Wenwen He, Yi Lu iD, Xiangjia Zhu iD

Clinical & Experimental Ophthalmology · 2023

DOI: 10.1111/ceo.14226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical & Experimental Ophthalmology, 2023. Verfasst von Keke Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Phacoemulsification, Lenses, Intraocular. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Science and Technology Innovation Action Plan of Shanghai Science and Technology Commission, The National Natural Science Foundation of China, Clinical Science and Technology Innovation Project of Shanghai Shenkang Hospital Development Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A new foldable brown diaphragm intraocular lens (IOL) was preclinically evaluated in vitro and in vivo by comparing its biocompatibility and biosafety with those of a commercially available IOL.

Methods

The new foldable iris‐diaphragm IOL is composed of hydrophobic acrylic material, with a transparent optical zone and surrounding brown diaphragm. Cellular experiments evaluating lens epithelial cell morphology, adhesion, and migration were conducted to exclude cytotoxic effects. Twelve New Zealand rabbits underwent implantation of a brown diaphragm IOL in one eye, whilst an additional 12 had a commercially available foldable IOL implanted, followed by slit‐lamp evaluations of inflammatory reactions and capsular opacification. Corneal endothelial cells density was measured before and after implantation. Aqueous humour samples were obtained weekly for liquid chromatography–tandem mass spectrometry (LC–MS/MS) analysis to investigate dye leakage from the brown‐diaphragm IOL. Following 12 weeks of observation, haematoxylin and eosin staining of ocular tissue and scanning electron microscopy (SEM) of the IOL surface were performed.

Results

Results from in vivo experiments found no statistically significant differences between the two groups in terms of postoperative inflammation and capsular biocompatibility. No significant changes in corneal endothelial cell density were observed in either group before and after surgery. LC–MS/MS analysis showed that the target dye was not detected in aqueous humour samples. Histopathology of ocular sections and SEM imaging of IOL surfaces showed similar changes in both groups.

Conclusions

The newly invented IOL showed good biocompatibility and biosafety. Combined with its foldability and peripheral shading, it could be a new choice for patients with iris defects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhacoemulsificationLenses, IntraocularAnimalsRabbitsLens Implantation, IntraocularDiaphragmChromatography, LiquidContainment of BiohazardsEndothelial CellsTandem Mass SpectrometryInflammationPostoperative Complications

Stichwörter der Autor:innen

brown diaphragmintraocular lensiris defectphacoemulsification

Autor:innen und Institutionen

  • Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
  • NHC Key Laboratory of Myopia (Fudan University), Shanghai, China.
  • Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
  • Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University, Shanghai, China.
  • State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, China.

ORCID-Profile: Yi Lu, Xiangjia Zhu

Förderung

  • Science and Technology Innovation Action Plan of Shanghai Science and Technology Commission
  • The National Natural Science Foundation of China
  • Clinical Science and Technology Innovation Project of Shanghai Shenkang Hospital Development Center
  • Shanghai Municipal Key Clinical Specialty
  • Science and Research Fund of Shanghai Health and Family Planning Commission
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, K., Zhang, S., He, W., Lu, Y., & Zhu, X. (2023). Preclinical biocompatibility and biosafety evaluation of a new foldable brown diaphragm intraocular lens: An in vitro and in vivo study. Clinical & Experimental Ophthalmology. https://doi.org/10.1111/ceo.14226

Vancouver

Zhang K, Zhang S, He W, Lu Y, Zhu X. Preclinical biocompatibility and biosafety evaluation of a new foldable brown diaphragm intraocular lens: An in vitro and in vivo study. Clinical & Experimental Ophthalmology. 2023. doi:10.1111/ceo.14226

BibTeX
@article{Zhang2023,
  author = {Zhang, Keke and Zhang, Shaohua and He, Wenwen and Lu, Yi and Zhu, Xiangjia},
  title = {Preclinical biocompatibility and biosafety evaluation of a new foldable brown diaphragm intraocular lens: An in vitro and in vivo study},
  journal = {Clinical & Experimental Ophthalmology},
  year = {2023},
  doi = {10.1111/ceo.14226}
}
Kostenlos starten →